Expressiona and Diagnostic Potential of miRNAs in NSCLC

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non Small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Cairo, 11231, Egypt

About this study

A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

First time and recently diagnosed NSCLC patient

Exclusion criteria

Recurrent NSCLC
Start of chemotherapy, radiotherapy or surgical intervention
Previous treatment
Cancer history

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

Determination of the expression

Time frame: By the end of the study (September 2022)

Expression profiling of the selected miRNAs

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Collaborators

National Cancer Institute, Cairo University, Egypt

Registry information

Official study title

The Expression Profiling of Serum miRNAs (106b-5p, 601, and 760) in Non-small Cell Lung Cancer Patients

Important dates

Study start: 2018
Primary completion: 2022
Study completion: 2022
First posted: Apr 18, 2023
Registry last updated: Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed